2011

Pharmacokinetics in Drug Development

Advances and Applications, Volume 3

Editors:

ISBN: 978-1-4419-7936-0 (Print) 978-1-4419-7937-7 (Online)

Table of contents (14 chapters)

  1. Front Matter

    Pages i-xii

  2. No Access

    Book Chapter

    Pages 1-19

    Modeling Tumor Growth in Oncology

  3. No Access

    Book Chapter

    Pages 21-56

    Drug–Drug Interactions: Designing Development Programs and Appropriate Product Labeling

  4. No Access

    Book Chapter

    Pages 57-90

    Modeling the Progression of Disease

  5. No Access

    Book Chapter

    Pages 91-114

    The Use of Dried Blood Spots for Concentration Assessment in Pharmacokinetic Evaluations

  6. No Access

    Book Chapter

    Pages 115-130

    Microdosing: Pharmacokinetic and Metabolism Data Early in the Drug Development Process

  7. No Access

    Book Chapter

    Pages 131-143

    Metabolite Testing in Drug Development

  8. No Access

    Book Chapter

    Pages 145-173

    The -Omics in Drug Development

  9. No Access

    Book Chapter

    Pages 175-193

    Optimal Design of Pharmacokinetic–Pharmacodynamic Studies

  10. No Access

    Book Chapter

    Pages 195-209

    Pharmacokinetic Studies in Pregnant Women

  11. No Access

    Book Chapter

    Pages 211-241

    Design, Conduct and Analysis of Thorough QT Studies

  12. No Access

    Book Chapter

    Pages 243-259

    Contribution of Quantitative Whole-Body Autoradioluminography to the Early Selection and Development of Drug Candidates

  13. No Access

    Book Chapter

    Pages 261-284

    Pharmacokinetics, Modeling, and Simulation in the Development of Sunitinib Malate: A Case Study

  14. No Access

    Book Chapter

    Pages 285-313

    The Clinical Significance of Drug Transporters in Drug Disposition and Drug Interactions

  15. No Access

    Book Chapter

    Pages E1-E1

    Erratum to: Modeling Tumor Growth in Oncology

  16. Back Matter

    Pages 315-319